Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 20,566 shares at $18.17 ($374K) on 2023-04-06, disclosed to the SEC on 2023-04-07.
Open-market sale of $374k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.17 | 10,283 | $187K | 50.0% |
| 2 | $18.17 | 10,283 | $187K | 50.0% |
| Total | $18.17 avg | 20,566 | $374K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |